← Evidence map

ArticleVaccine: X2024

Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2.

Nagashige Shimada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2. | Socratic